Dergiler / Turkish Journal of Biology / 2021 / Cilt: 45 - Sayı: 1

Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest

Sayfa
104–113
Yayın Tarihi
2021-02-09
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We also made the data on Turkey isolates available on an online database to facilitate further research on SARS-CoV-2 mutations in Turkey.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:As the underlying pathogen for the COVID-19 pandemic that has affected tens of millions of lives worldwide, SARS-CoV-2 and its mutations are among the most urgent research topics worldwide.
📊
Temel Bulgular & Veri:Mutations in the virus genome can complicate attempts at accurate testing or developing a working treatment for the disease.
💡
Sonuç & Katkı:We also made the data on Turkey isolates available on an online database to facilitate further research on SARS-CoV-2 mutations in Turkey.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:COVID-19 · SARS-CoV-2 · coronavirus

Abstract

As the underlying pathogen for the COVID-19 pandemic that has affected tens of millions of lives worldwide, SARS-CoV-2 and its mutations are among the most urgent research topics worldwide. Mutations in the virus genome can complicate attempts at accurate testing or developing a working treatment for the disease. Furthermore, because the virus uses its own proteins to replicate its genome, rather than host proteins, mutations in the replication proteins can have cascading effects on the mutation load of the virus genome. Due to the global, rapidly developing nature of the COVID-19 pandemic, local demographics of the virus can be difficult to accurately analyze and track, disproportionate to the importance of such information. Here, we analyzed available, high-quality genome data of SARS-CoV-2 isolates from Turkey and identified their mutations, in comparison to the reference genome, to understand how the local mutatome compares to the global genomes. Our results indicate that viral genomes in Turkey has one of the highest mutation loads and certain mutations are remarkably frequent compared to global genomes. We also made the data on Turkey isolates available on an online database to facilitate further research on SARS-CoV-2 mutations in Turkey.

🔖

Bu Makaleye Atıf Yap

ESKİER, D., AKALP, E., DALAN, Ö., KARAKÜLAH, G., OKTAY, Y. (2021). Current mutatome of SARS-CoV-2 in Turkey reveals mutations of interest. Turkish Journal of Biology, Cilt: 45 - Sayı: 1, 104–113. https://ajindex.com/articles/197896

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Ayub MI, 2020, REPORTING 2 SARS COV, DOI [10.20944/preprints202004.0337.v1, DOI 10.20944/PREPRINTS202004.0337.V1] Chan JFW, 2020,
  2. LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9 Daniloski Zharko, 2020, bioRxiv, DOI 10.1101/2020.06.14.151357 Deng W, 2020,
  3. SCIENCE, V369, P818, DOI 10.1126/science.abc5343 Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018 Eskier D, 2020,
  4. BIORXIV, DOI [10.1101/2020.08.12.248732, DOI 10.1101/2020.08.12.248732] Eskier D, 2020,
  5. PEERJ, V8, DOI 10.7717/peerj.9703 Eskier D, 2020,
  6. PEERJ, V8, DOI 10.7717/peerj.9587 Grifoni A, 2020,
  7. CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015 Hachim A, 2020, NAT IMMUNOL, V21, P1293, DOI 10.1038/s41590-020-0773-7 Hadfield J, 2018,
  8. BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407 Hue S, 2020, AM J RESP CRIT CARE, V202, P1509, DOI 10.1164/rccm.202005-1885OC Jungreis Irwin, 2020, bioRxiv, DOI 10.1101/2020.06.02.130955 Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436 Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3 Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479 Korber B, 2020,
  9. CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043 Lee IC, 2020, J CHIN MED ASSOC, V83, P521, DOI 10.1097/JCMA.0000000000000319 Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728 MacLean OA, 2020,
  10. NATURAL SELECTION EV, DOI [10.1101/2020.05.28.122366, DOI 10.1101/2020.05.28.122366] McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991 Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6 Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000056 Peng Q, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107774 Riou J, 2020,
  11. EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058 Romano M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051267 Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042 Simmonds P, 2020,
  12. BIORXIV, DOI [10.1101/2020.05.01.072330, DOI 10.1101/2020.05.01.072330] Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111 Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7 Tylor S, 2009, CAN J MICROBIOL, V55, P254, DOI [10.1139/W08-139, 10.1139/w08-139] Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603 Wong J, 2020, INFLUENZA OTHER RESP, V14, P596, DOI 10.1111/irv.12767 Yin CC, 2020,
  13. GENOMICS, V112, P3588, DOI 10.1016/j.ygeno.2020.04.016 Zhu H, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01292-3